Mepolizumab in severe asthma exacerbation in a respiratory ICU-a successful off-label use

Pulmonology. 2023 Sep-Oct;29(5):438-440. doi: 10.1016/j.pulmoe.2023.03.002. Epub 2023 Apr 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Asthma* / drug therapy
  • Humans
  • Intensive Care Units
  • Off-Label Use*

Substances

  • mepolizumab
  • Antibodies, Monoclonal, Humanized